Takihyo Co., Ltd. (Head office: Nishi　Ward, Nagoya City; Representative Director,　President and CEO: Kazuo Taki) will begin sales of its recovery wear registered as a general medical device in June 2026. The product uses a mechanism that promotes blood circulation through a unique resonance effect developed by Rezona Bio LAB Co., Ltd. (Location: Uruma City, Okinawa Prefecture; Representative Director and President: Shingo Matsunaga), and will be rolled out sequentially to mass market retailers nationwide.

■ Features of This Product
• A Unique Mechanism for Promoting Blood Flow Through “Resonance”
This product utilizes the “resonance” effect generated by matching the frequencies of the far-infrared rays emitted by the skin with those emitted by special fibers.
These subtle vibrations stimulate the body and promote blood flow.

• An exceptionally soft touch and comfortable fit thanks to the “cotton blend”
Because these are items worn every day and for bedtime, we have paid special attention to the materials. While many products on the market are made primarily of synthetic fibers (such as polyester), this new release contains approximately 45% cotton. It offers a soft feel on the skin and excellent sweat absorbency, making your relaxation time even more comfortable.

• Supported by evidence obtained through registration as a general medical device
Through collaboration with Rezona Bio LAB Co., Ltd., we have obtained evidence supporting its classification as a general medical device.
(Medical device notification No.: 47B3X10001TH0001)

Going forward, we plan to expand our product lineup to include a variety of materials in addition to our current T-shirt and sweatshirt fabrics, so that we may help you rest comfortably throughout the seasons and in various settings. Furthermore, we will proactively address the needs of children and school-age generations, a demographic that has been underserved in the market until now, and support “high-quality rest and recovery” for people of all ages.